Skip to main content

Table 2 Correlation analysis between relapse compartment and survival time stratified according to secondary therapy; n = 87

From: Site of relapse of ductal adenocarcinoma of the pancreas affects survival after multimodal therapy

Recurrence/metastases Total Surgery Chemotherapy p-value
0.000
n % n % n %
Hepatic 43   6   37   
Local 28   11   17   
Pulmonary 17   9   8   
Relapse Chemotherapy/procedure Hepatic, n Local, n Pulmonary, n p-value
0.900
Gemcitabine 27 12 5  
MD regime 10 5 3  
FOLFIRINOX  
BSC  
  1. Fisher exact test was used to test for statistical significance. p-value ≤ 0.05 indicates significance
  2. BSC best supportive care, MD multi-drug